ALX Oncology to Participate in Upcoming Investor Conferences in September
ALX Oncology (NASDAQ:ALXO), a clinical-stage biotech company focused on cancer therapies, has announced its participation in two upcoming investor conferences in September 2025. The company will attend the Cantor Global Healthcare Conference on September 3, featuring a fireside chat at 9:45 AM ET, and the H.C. Wainwright 27th Annual Global Investment Conference on September 9.
Both events will be held in New York and will include one-on-one meetings. Webcasts of the presentations will be available on ALX Oncology's website and archived for up to 90 days.
ALX Oncology (NASDAQ:ALXO), azienda biofarmaceutica in fase clinica focalizzata sulle terapie antitumorali, ha annunciato la partecipazione a due conferenze per investitori previste per settembre 2025. La societ脿 sar脿 presente al Cantor Global Healthcare Conference il 3 settembre, con un fireside chat alle 9:45 AM ET, e all'H.C. Wainwright 27th Annual Global Investment Conference il 9 settembre.
Entrambi gli eventi si terranno a New York e includeranno incontri one-to-one. Le webcast delle presentazioni saranno disponibili sul sito di ALX Oncology e archiviate per un massimo di 90 giorni.
ALX Oncology (NASDAQ:ALXO), una biotecnol贸gica en fase cl铆nica centrada en terapias contra el c谩ncer, ha anunciado su participaci贸n en dos conferencias para inversores en septiembre de 2025. La compa帽铆a asistir谩 al Cantor Global Healthcare Conference el 3 de septiembre, con un fireside chat a las 9:45 AM ET, y al H.C. Wainwright 27th Annual Global Investment Conference el 9 de septiembre.
Ambos eventos se celebrar谩n en Nueva York e incluir谩n reuniones individuales. Las retransmisiones en directo de las presentaciones estar谩n disponibles en la web de ALX Oncology y se archivar谩n hasta por 90 d铆as.
ALX Oncology (NASDAQ:ALXO), 鞎� 旃橂鞝� 臧滊皽鞐� 欤茧牓頃橂姅 鞛勳儊 雼硠 氚旍澊鞓り赴鞐呾澊 2025雲� 9鞗� 臧滌禍霅橂姅 霊� 瓯挫潣 韴瀽鞛� 旎嵓霟办姢 彀胳棳毳� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 9鞗� 3鞚� Cantor Global Healthcare Conference鞐愳劀 鞓れ爠 9鞁�45攵�(霃欕秬鞁滉皠)鞐� 韺岇澊鞏挫偓鞚措摐 毂勴寘鞚� 歆勴枆頃橁碃, 9鞗� 9鞚检棎電� H.C. Wainwright 27th Annual Global Investment Conference鞐� 彀胳劃頃╇媹雼�.
霊� 頄夓偓電� 氇憪 雺挫殨鞐愳劀 鞐措Μ氅� 鞚茧寑鞚� 氙疙寘霃� 鞓堨爼霅橃柎 鞛堨姷雼堧嫟. 氚滍憸 鞗轨簮鞀ろ姼電� ALX Oncology 鞗轨偓鞚错姼鞐愳劀 鞁滌箔頃� 靾� 鞛堨溂氅� 斓滊寑 90鞚缄皠 鞎勳勾鞚措笇霅╇媹雼�.
ALX Oncology (NASDAQ:ALXO), soci茅t茅 biotechnologique en phase clinique sp茅cialis茅e dans les traitements du cancer, a annonc茅 sa participation 脿 deux conf茅rences investisseurs en septembre 2025. La soci茅t茅 assistera au Cantor Global Healthcare Conference le 3 septembre, avec un fireside chat 脿 9h45 (ET), et au H.C. Wainwright 27th Annual Global Investment Conference le 9 septembre.
Les deux 茅v茅nements se tiendront 脿 New York et comprendront des r茅unions individuelles. Les webcasts des pr茅sentations seront disponibles sur le site d'ALX Oncology et archiv茅s pendant 90 jours au maximum.
ALX Oncology (NASDAQ:ALXO), ein biopharmazeutisches Unternehmen in der klinischen Phase mit Schwerpunkt auf Krebstherapien, hat seine Teilnahme an zwei Investorenkonferenzen im September 2025 angek眉ndigt. Das Unternehmen wird am Cantor Global Healthcare Conference am 3. September mit einem Fireside-Chat um 9:45 Uhr ET sowie am H.C. Wainwright 27th Annual Global Investment Conference am 9. September teilnehmen.
Beide Veranstaltungen finden in New York statt und umfassen Einzelgespr盲che. Webcasts der Pr盲sentationen werden auf der Website von ALX Oncology verf眉gbar sein und bis zu 90 Tage archiviert.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients鈥� lives, today announced that ALX Oncology leadership will participate in both the Cantor Global Healthcare Conference 2025 and H.C. Wainwright 27th Annual Global Investment Conference in New York.
The details of the meetings are as follows:
Cantor Global Healthcare Conference
Format: Fireside Chat and One-on-one Meetings
Date: Wednesday, September 3, 2025
Location: New York, NY
Time of Fireside Chat Presentation: 9:45 AM ET
Webcast link: Available
H.C. Wainwright 27th Annual Global Investment Conference
Format: One-on-one meetings
Date: Tuesday, September 9, 2025
Location: New York, NY
Webcast link: Pre-recorded fireside chat presentation available
The webcasts of the Cantor and H.C. Wainwright fireside chats can be accessed by visiting the Investors section of ALX Oncology鈥檚 website at under the section of the Events and Presentations tab. Replays of the webcasts will be archived for up to 90 days following the fireside chat dates.
About ALX Oncology
ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients鈥� lives. ALX Oncology鈥檚 lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. ALX Oncology鈥檚 second pipeline candidate, ALX2004, is a novel EGFR-targeted antibody-drug conjugate with a differentiated mechanism of action and entered the clinic in a Phase 1 trial in August 2025. More information is available at聽聽and on LinkedIn聽.
Investor Relations Contact:
Elhan Webb, CFA, IR Consultant
Media Contact:
Audra Friis, Sam Brown Healthcare Communications
(917) 519-9577
FAQ
When is ALX Oncology (ALXO) presenting at the Cantor Global Healthcare Conference 2025?
Where can I watch ALX Oncology's (ALXO) investor conference presentations?
Which investor conferences is ALX Oncology (ALXO) attending in September 2025?
What type of company is ALX Oncology (ALXO)?
